Embolization and postinfarction nephrectomy in patients with primary metastatic renal adenocarcinoma
Kurth, K.H.; Debruyne, F.M.; Hall, R.R.; Denis, L.; Verbaes, A.; Bollack, C.; de Voogt, H.J.; de Pauw, M.; Silvester, R.
European Urology 13(4): 251-255
1987
ISSN/ISBN: 0302-2838 PMID: 3653165 Document Number: 305392
In a phase-II study of the EORTC GU Group 34 patients with metastatic renal cell carcinoma were treated by angioinfarction and delayed nephrectomy. The mortality of the procedure was 5.8%. One patient had a complete remission. 80% of the patients showed progression within 6 months after nephrectomy. The median survival of the patients was 25 weeks, 65% of the patients died within 1 year after nephrectomy.